Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health … H Strongman, S Gadd, A Matthews, KE Mansfield, S Stanway, AR Lyon, ... The Lancet 394 (10203), 1041-1054, 2019 | 380 | 2019 |
Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study KE Mansfield, R Mathur, J Tazare, AD Henderson, AR Mulick, H Carreira, ... The Lancet Digital Health 3 (4), e217-e230, 2021 | 319 | 2021 |
Incidence, prevalence, and survival of patients with idiopathic pulmonary fibrosis in the UK H Strongman, I Kausar, TM Maher Advances in therapy 35, 724-736, 2018 | 211 | 2018 |
Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications S Padmanabhan, L Carty, E Cameron, RE Ghosh, R Williams, ... European journal of epidemiology 34, 91-99, 2019 | 203 | 2019 |
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review A Matthews, S Stanway, RE Farmer, H Strongman, S Thomas, AR Lyon, ... bmj 363, 2018 | 125 | 2018 |
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries P Korhonen, EM Heintjes, R Williams, F Hoti, S Christopher, M Majak, ... Bmj 354, 2016 | 73 | 2016 |
Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: a matched cohort study using linked English electronic health records data H Carreira, H Strongman, M Peppa, HI McDonald, I dos-Santos-Silva, ... EClinicalMedicine 29, 2020 | 60 | 2020 |
Does cardiovascular mortality overtake cancer mortality during cancer survivorship? An English retrospective cohort study H Strongman, S Gadd, AA Matthews, KE Mansfield, S Stanway, AR Lyon, ... Cardio Oncology 4 (1), 113-123, 2022 | 49 | 2022 |
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records JL Walker, DJ Grint, H Strongman, RM Eggo, M Peppa, C Minassian, ... BMC public health 21, 1-14, 2021 | 39 | 2021 |
COVID-19 in Great Britain: epidemiological and clinical characteristics of the first few hundred (FF100) cases: a descriptive case series and case control analysis NL Boddington, A Charlett, S Elgohari, JL Walker, HI McDonald, C Byers, ... MedRxiv, 2020.05. 18.20086157, 2020 | 33 | 2020 |
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study H Strongman, S Christopher, M Majak, R Williams, S Bahmanyar, ... BMJ Open Diabetes Research and Care 6 (1), e000481, 2018 | 33 | 2018 |
Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals H Strongman, A Brown, L Smeeth, K Bhaskaran British journal of cancer 120 (7), 768-770, 2019 | 30 | 2019 |
What are the implications of using individual and combined sources of routinely collected data to identify and characterise incident site-specific cancers? a concordance and … H Strongman, R Williams, K Bhaskaran BMJ open 10 (8), e037719, 2020 | 28 | 2020 |
Linking electronic health data in pharmacoepidemiology: Appropriateness and feasibility DR Rivera, MN Gokhale, MW Reynolds, EB Andrews, D Chun, K Haynes, ... Pharmacoepidemiology and Drug Safety 29 (1), 18-29, 2020 | 27 | 2020 |
Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review H Carreira, R Williams, H Strongman, K Bhaskaran BMJ open 9 (7), e029227, 2019 | 25 | 2019 |
Identification of mental health and quality of life outcomes in primary care databases in the UK: a systematic review H Carreira, R Williams, H Strongman, K Bhaskaran | 25* | |
Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink H Strongman, H Carreira, BL De Stavola, K Bhaskaran, DA Leon PLoS Medicine 19 (1), e1003870, 2022 | 24 | 2022 |
Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study C Warren-Gash, JA Davidson, H Strongman, E Herrett, L Smeeth, ... The Lancet Regional Health–Europe 27, 2023 | 19 | 2023 |
Limitations for health research with restricted data collection from UK primary care H Strongman, R Williams, W Meeraus, T Murray‐Thomas, J Campbell, ... Pharmacoepidemiology and drug safety 28 (6), 777-787, 2019 | 16 | 2019 |
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study H Strongman, P Korhonen, R Williams, S Bahmanyar, F Hoti, ... BMJ Open Diabetes Research and Care 5 (1), e000364, 2017 | 15 | 2017 |